By Kevin E. Noonan — The decision by the Patent Trial and Appeal Board (PTAB) in favor of Senior Party the Broad Institute, Harvard University, and MIT (collectively, "Broad") and against Junior Party the University of California/Berkeley, the University of Vienna, and Emmanuelle Charpentier (collectively, "CVC") sixteen months ago in the latest CRISPR interference No. 106,115 is the subject of appeal from both parties. CVC filed its brief on September 20, 2022; Broad (discussed herein) filed its (corrected) Responsive Brief (which included a Contingent Cross-Appeal in the event the Federal Circuit did not affirm the PTAB’s decision below) on February…
